New Delhi, Dec. 15 -- Corona Remedies' initial public offering (IPO) is all set to make its stock market debut today, December 15, after gaining strong investors response during the three days subscription period.

The Corona Remedies IPO saw overwhelming demand during its three-day subscription window, with investors bidding for 6,26,54,14,440 shares against the 45,71,882 shares on offer, translating into an overall subscription of 137.04 times.

Qualified Institutional Buyers (QIBs) led the bidding activity, subscribing to the issue 278.52 times. They placed bids for 35,89,39,448 shares, far exceeding the 12,88,732 shares reserved for them by the end of the final day of bidding.

Arun Kejriwal, Founder of Kejriwal Research and Investmen...